Gefitinib: Clinical Trials

1 unknown. .

Follow Gefitinib: new trials by email Literature Review of Gefitinib trials Research Report on Gefitinib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET sorafenib, gefitinib - Pancreatic Neuroendocrine Neoplasm, Sorafenib		Unknown	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	20	2024-09-30	2025-01-10

Narrower conditions

Adenoma, Islet Cell (1)

Broader conditions

Adenoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pancreatic Diseases (1)  ·  Pancreatic Neoplasms (1)

Interventions

Gefitinib (1)  ·  Sorafenib (1)

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Top investigators

Jiang Long, M.D. (1)  ·  Jiuliang Yan, M.D. (1)

Results publications

PMID 19704057, PMID 26703889, PMID 30833272, PMID 31555796, PMID 33788183, PMID 34012671, PMID 34388377, PMID 35348774, PMID 36140756, PMID 36891979, PMID 37774329, PMID 38610840